Baboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease

Similar documents
Diagnostic Testing Algorithms for Celiac Disease

Activation of Innate and not Adaptive Immune system in Gluten Sensitivity

New Insights on Gluten Sensitivity

Diseases of the gastrointestinal system Dr H Awad Lecture 5: diseases of the small intestine

Challenges in Celiac Disease. Adam Stein, MD Director of Nutrition Support Northwestern University Feinberg School of Medicine

Diagnosis Diagnostic principles Confirm diagnosis before treating

Gluten Sensitivity Fact from Myth. Disclosures OBJECTIVES 18/09/2013. Justine Turner MD PhD University of Alberta. None Relevant

November Laboratory Testing for Celiac Disease. Inflammation in Celiac Disease

Primary Care Update January 26 & 27, 2017 Celiac Disease: Concepts & Conundrums

See Policy CPT CODE section below for any prior authorization requirements

Disclosures GLUTEN RELATED DISORDERS CELIAC DISEASE UPDATE OR GLUTEN RELATED DISORDERS 6/9/2015

Is It Celiac Disease or Gluten Sensitivity?

BIOPSY AVOIDANCE IN CHILDREN: THE EVIDENCE

L y mp h o c y t i c D i s o r d e r s of t h e. What does too many mean? Unifying theory 2/24/2011

Immune mediated enteropathies. Aurora Tatu Bern 26/07/2017

Celiac Disease and Non Celiac Gluten Sensitivity. John R Cangemi, MD Mayo Clinic Florida

Celiac disease Crohn s disease Ulcerative colitis Pseudomembranous colitis

DEAMIDATED GLIADIN PEPTIDES IN COELIAC DISEASE DIAGNOSTICS

Meredythe A. McNally, M.D. Gastroenterology Associates of Cleveland Beachwood, OH

Celiac & Gluten Sensitivity; serum

Celiac Disease Ce. Celiac Disease. Barry Z. Hirsch, M.D. Baystate Pediatric Gastroenterology and Nutrition. baystatehealth.org/bch

Epidemiology. The old Celiac Disease Epidemiology:

DDW WRAP-UP 2012 CELIAC DISEASE. Anju Sidhu MD University of Louisville Gastroenterology, Hepatology and Nutrition June 21, 2012

Celiac Disease: The Quintessential Autoimmune Disease Ivor D. Hill, MB, ChB, MD.

Celiac Disease: The Future. Alessio Fasano, M.D. Mucosal Biology Research Center University of Maryland School of Medicine

CELIAC DISEASE - GENERAL AND LABORATORY ASPECTS Prof. Xavier Bossuyt, Ph.D. Laboratory Medicine, Immunology, University Hospital Leuven, Belgium

Celiac Disease. Detlef Schuppan HARVARD MEDICAL SCHOOL

Coeliac disease. Do I have coeliac. disease? Diagnosis, monitoring & susceptibilty. Laboratory flowsheet included

Understanding Celiac Disease

Peter HR Green MD. Columbia University New York, NY

Larazotide Acetate. Alessio Fasano, M.D. Mucosal Biology Research Center and Center for Celiac Research University of Maryland School of Medicine

International Journal of Health Sciences and Research ISSN:

Understanding Celiac Disease

Gluten sensitivity in Multiple Sclerosis Experimental myth or clinical truth?

No relevant financial relationships to disclose

Sheila E. Crowe, MD, FACG

Gluten-Free China Gastro Q&A

The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.

Celiac Disease: You ve Come A Long Way Baby!

Celiac Disease For Dummies By Sheila Crowe, Ian Blumer READ ONLINE

Celiac disease is a unique disorder that is both a food

The first and only fully-automated, random access, multiplex solution for Celiac IgA and Celiac IgG autoantibody testing.

Gluten-Free Living: Helping People to Eat Safely, Healthfully and Happily

Diet Isn t Working, We Need to Do Something Else

The Clinical Response to Gluten Challenge: A Review of the Literature

Saeeda Almarzooqi, 1 Ronald H. Houston, 2 and Vinay Prasad Introduction

Spectrum of Gluten Disorders

ORIGINAL ARTICLE: Clinical Endoscopy

Presentation and Evaluation of Celiac Disease

Clinical updates on diagnosing glutensensitive enteropathy

Evidence Based Guideline

Celiac Disease 1/13/2016. Objectives. Question 1. Understand the plethora of conditions or symptoms that require testing for Celiac Disease (CD)

Esperanza Garcia-Alvarez MD Medical Director Pediatric Celiac Center at Advocate Children s Hospital

Functional Medicine Is the application of alternative holistic measures to show people how to reverse thyroid conditions, endocrine issues, hormone

University of Tampere, Faculty of Medicine and Life Sciences Arvo building, Arvo Ylpön katu 34, Tampere, Finland

DIFFERENTIATING GLUTEN RELATED DISORDERS

Update on Celiac Disease: New Standards and New Tests

2013 NASPGHAN FOUNDATION

Genetics and Epidemiology of Celiac Disease

Celiac Disease. Educational Gaps. Objectives. Tracy R. Ediger, MD, PhD,* Ivor D. Hill, MB, CHB, MD

Am I a Silly Yak? Laura Zakowski, MD. No financial disclosures

CONTEMPORARY CONCEPT ON BASIC APSECTS OF GLUTEN-SENSITIVE ENTEROPATHY IN ELDERLY PATIENTS

Gluten and the skin: Celiac disease and gluten sensitivity for the dermatologist

Celiac Disease. Sheryl Pfeil, MD The Ohio State University Division of Gastroenterology, Hepatology, and Nutrition. January 2015

CELIAC DISEASE. Molly Jennings Deb McCafferty MS, RD

Recent advances in celiac disease

Celiac Disease. Samuel Gee (1888) first described Celiac disease in On the Coeliac Affection Gluten sensitive entropathy Non-tropical sprue

Celiac disease (CD) is a gluten-sensitive enteropathy with. Comparative Usefulness of Deamidated Gliadin Antibodies in the Diagnosis of Celiac Disease

Organic - functional. Opposing views. Simple investigation of GI disorders. The dollar questions. Immune homeostasis of mucosa

GI Manifestations of Food Allergy

Natural History of Antibodies to Deamidated Gliadin Peptides and Transglutaminase in Early Childhood Celiac Disease

Three Hidden Ways Wheat Makes You Fat

CELIAC SPRUE. What Happens With Celiac Disease

Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy

Celiac Disease: The Past and The Present

EAT ACCORDING TO YOUR GENES. NGx-Gluten TM. Personalized Nutrition Report

OHTAC Recommendation

Celiac Disease. Gluten-Sensitive Enteropathy Celiac Sprue Non-tropical Sprue

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia

Our simple 3 step process to help you discover if gluten could be a problem for you!

5/27/2014 WEBINAR. Suggested CDR Learning Codes: 3000, 5000, 5110, 5220; Level 2

The challenge of tackling Campylobacter in Belgium

Utility in Clinical Practice of Immunoglobulin A Anti-Tissue Transglutaminase Antibody for the Diagnosis of Celiac Disease

Autoimmune Diseases and Therapeutic Approaches. Celiac Disease: A Brief Review of Current Literature

What s New in Eosinophilic GI Disorders & Celiac Disease. John Garber, MD Gastrointestinal Unit Massachusetts General Hospital Harvard Medical School

A young woman with fatigue

Celiac Disease and Gluten Sensitivity: New Tests and Approaches

Food Allergies: Fact from Fiction

Celiac Disease. Etiology. Food Intolerance:Celiac Disease and Gluten Sensitivity-A Guide for Healthy Lifestyles

The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet

Improving allergy outcomes. IgE and IgG 4 food serology in a Gastroenterology Practice. Jay Weiss, Ph.D and Gary Kitos, Ph.D., H.C.L.D.

Name of Policy: Serologic Diagnosis of Celiac Disease

Paediatric Food Allergy and Intolerance. Abigail Macleod, Associate Specialist, RBH

Diagnostic and Management Dilemmas in Celiac Disease

By Mathew P. Estey, PhD, FCACB; and Vilte E. Barakauskas, PhD, DABCC, FCACB

Alliance for Best Practice in Health Education

University of Tampere, Faculty of Medicine and Life Sciences Arvo Building, Arvo Ylpön katu 34, Tampere, Finland

Seriously, CELIAC. talk.

Slides and Resources.

The Significance of IgG Antibodies against Tissue Transglutaminase in Coeliac Disease

Transcription:

Baboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease Debby Kryszak 1, Henry McGill 2, Michelle Leland 2,, Alessio Fasano 1 1. Center for Celiac Research, University of Maryland School of Medicine 2. Southwest Foundation for Biomedical Research, San Antonio, TX

Baboons Affected by Hereditary Chronic Diarrhea as a Possible Non-Human Primate Model of Celiac Disease Background: Celiac disease (CD) represents a unique model of autoimmunity in which, in contrast to most other autoimmune diseases, a close genetic association with HLA genes (DQ2 and/or DQ8), a highly specific humoral autoimmune response (autoantibodies to tissue transglutaminase IgG, (ttg-igg)), and, most importantly, the triggering environmental factor (gluten), are known. Given the undisputable role of gluten in causing inflammation and immune-mediated tissue damage, CD could provide unique opportunities to tackle the pathogenic basis of autoimmune processes. However, the lack of an animal model of the disease represents a major limitation in reaching goals. Aims: To establish if the pedigreed colony of baboons with hereditary chronic diarrhea at the Southwest Foundation for Biomedical Research (SFBR), could be used as a possible non-human primate model for celiac disease. Methods: Phase I: The collection of the serum and biopsies samples to determined whether the chronic diarrhea experienced by these baboons could be secondary to gluten induced enteropathy. Phase II: Baboons admitted to the SFBR veterinary clinic with chronic diarrhea were placed on a Gluten Free Diet and monitored for 6 months. Blood samples and duodenal biopsies were collected at baseline, midway (3 months) and at the conclusion of the study. Results: All of the baboons have had a 10% weight gain and become free of diarrhea, within the first 4-6 weeks of starting the gluten free diet. Currently there are three baboons which have completed the study. These baboons are currently in the general colony on a regular baboon diet. Baboon 19656: Baseline: duodenal biopsies showed patchy villous blunting with an increase in intraepithelial lymphocytes, crypt hyperplasia, some signs of mitosis in the crypts, a decreased villous crypt ratio and a elevated tissue transglutaminase-igg (ttg- IgG) and Zonulin levels. Midway (3 months): duodenal biopsies showed a normalization of the villous architecture number of intraepithelial lymphocytes, villous crypt ratio and ttg-igg and zonulin levels. Conclusion (6 months): duodenal biopsies continued to show normalization of the villous architecture with a slight increase in the number of intraepithelial lymphocytes (as compared to 3 month biopsy) The ttg-igg and zonulin levels continued to be normal. Baboon 16102: Baseline: duodenal biopsies showed a normal villous architecture with large increase intraepithelial lymphocytes focal inflammation, slight crypt hyperplasia, a positive tissue ttg-igg and normal zonulin level. Midway (3 months): duodenal biopsy showed: a decrease in inflammation and a decrease in intraepithelial lymphocytes (as compared to baseline month biopsy). The ttg-igg remained positive and the zonulin remained negative. Conclusion (6 months): duodenal biopsy continued to show a decrease in inflammation and a decrease in intraepithelial lymphocytes (as compared to 3 month biopsy). The ttg-igg remained positive and the zonulin remained negative. Baboon 20008: Baseline: duodenal biopsies showed a moderate increase intraepithelial lymphocytes, crypt hyperplasia, deep crypts, inflammation in the lamina propria and a normal ttg-igg and a elevated zonulin level. Midway (3 months): duodenal biopsy was unavailable. The ttg-igg remained normal while the zonulin decreased to a normal level. Conclusion (6 months): duodenal biopsy showed a show normal villous architecture and villous crypt ratio. The ttg-igg and zonulin levels remained normal. Conclusions: These preliminary observations suggest that a gluten-dependent enteropathy is present in the pedigreed baboon colony studied. The clinical, serological, and histological features suggest a similarity to human CD and, therefore, that the progeny of this sire can be potentially used as a primate non-human model of CD.

Background The Southwest Foundation for Biomedical Research (SFBR) in San Antonio, TX has a pedigreed baboon colony (population ~3000) that has had a problem of managing chronic diarrhea since the inception of the colony in 1972. Infectious agents have been excluded and preliminary analysis of the distribution of diarrhea in the baboons at the SFBR, shows a concentration of the affected animals among the progeny of 4 sires that span 6 generations.

Aims To establish if the pedigreed colony of baboons with hereditary chronic diarrhea at the Southwest Foundation for Biomedical Research, could be used as a possible non-human primate model for celiac disease.

Methods: Animal Selection 4200 Baboons were reviewed from 57 sires 4037 Healthy 163 Chronic Diarrhea without an infection 23 Controls ttg-igg Zonulin Duodenal Biopsy and Necropsy specimens 112 (69%) From 53 sires (~2 cases/sire) 51 (31%) From 4 sires (~13 cases/sire) 19 Chronic Diarrhea cases ttg-igg Zonulin Duodenal Biopsy and Necropsy specimens

Presumptive Evidence that the Chronic Diarrhea Condition is Hereditary 40% of the off spring from one of the 4 original sires developed non-infective chronic diarrhea

Percent Positive Serology Results: Phase I 30 25 20 15 10 5 0 ttg-igg Zonulin Baboons with Chronic Diarrhea Healthy Baboons

Zonulin ng/mg protein Serology: Phase I Correlation between positive ttg-igg and elevated Zonulin levels 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 y = 0.1411x + 0.4109 R 2 = 0.6381 0.0 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 ttg-igg AU

Histology: Phase I Duodenal tissues from a Healthy Baboon Normal Villous Architecture

Histology: Phase I Duodenal tissues from Baboons with chronic diarrhea Increased Intraepithelial lymphocytes Patchy Villous Blunting

Weight (kgs) Intervention with the Gluten free Diet 8 7 6 5 4 3 2 1 Supportive therapy Supportive therapy Supportive therapy Euthanized GFD Supportive therapy 0 0 0.5 1 1.5 2 2.5 3 Age (years) Supportive Therapy: Gatorade, fruit and vegetables and the usual baboon (gluten containing) chow

Results: Phase II Baboon #19656, 2 years old Baseline 3 Months on a GFD 6 Months on a GFD ttg-igg 9.1 1.8 5.3 (Cutoff: 6.6AU) Zonulin 6.32 <0.02 0.03 (Cutoff: 1.69ng/mg)

Results: Phase II Baboon #16102, 6 years old Baseline 3 Months on a GFD 6 Months on a GFD ttg-igg 6.9 9.9 13.5 (Cutoff: 6.6AU) Zonulin.047 0.40 <0.02 (Cutoff: 1.69ng/mg)

Results: Phase II Baboon #20008, 3 years old Baseline 3 Months on a GFD 6 Months on a GFD ttg-igg 4.2 4.1 5.9 (Cutoff: 6.6AU) Zonulin 7.04 <0.02 <0.02 (Cutoff: 1.69ng/mg)

Results: Phase II All of the baboons have had a 10% weight gain and become free of diarrhea, within the first 4-6 weeks of starting the gluten free diet. Baboon 19656: Baseline: duodenal biopsies showed patchy villous blunting with an increase in intraepithelial lymphocytes, crypt hyperplasia, some signs of mitosis in the crypts, a decreased villous crypt ratio and an elevated tissue transglutaminase-igg (ttg-igg) and Zonulin levels. Midway (3 months): duodenal biopsies showed a normalization of the villous architecture, number of intraepithelial lymphocytes, villous crypt ratio, ttg-igg and zonulin levels. Conclusion (6 months): duodenal biopsies continued to show normalization of the villous architecture with a slight increase in the number of intraepithelial lymphocytes (as compared to 3 month biopsy) The ttg-igg and zonulin levels continued to be normal. Baboon 16102: Baseline: duodenal biopsies showed a normal villous architecture with large increase of intraepithelial lymphocytes, focal inflammation, slight crypt hyperplasia, a positive tissue ttg-igg and normal zonulin level. Midway (3 months): duodenal biopsy showed a decrease in inflammation and a decrease in intraepithelial lymphocytes (as compared to baseline biopsy). The ttg-igg remained positive and the zonulin remained negative. Conclusion (6 months): duodenal biopsy continued to show a decrease in inflammation and a decrease in intraepithelial lymphocytes (as compared to 3 month biopsy). The ttg-igg remained positive and the zonulin remained negative. Baboon 20008: Baseline: duodenal biopsies showed a moderate increase in intraepithelial lymphocytes, crypt hyperplasia, deep crypts, inflammation in the lamina propria, a normal ttg-igg and a elevated zonulin level. Midway (3 months): duodenal biopsy was unavailable. The ttg-igg remained normal while the zonulin decreased to a normal level. Conclusion (6 months): duodenal biopsy showed normal villous architecture and villous crypt ratio. The ttg-igg and zonulin levels remained normal.

Results: Phase II Currently there are three baboons which have completed Phase II of the study. These baboons are currently in the general colony on a regular baboon diet. The 3 baboons all had a 10% weight gain and no diarrhea after 4-6 weeks from starting the GFD. None of the 3 baboons have been readmitted to the clinic for diarrhea after completing the study.

Conclusions Within the first 4-6 weeks of starting on the GF baboon chow, the three baboons enrolled in the study continued to gain weight and their diarrhea resolved. The sire effect is presumptive evidence that the condition is hereditary. The clinical, serological, and histological features and the response to the GFD (both clinically and histological) suggest a similarity to human CD and, therefore, that the progeny of the 4 sires of this pedigreed colony can be potentially used as a primate non-human model of CD.